Bloomage BioTechnology H1 2026 revenue, profit fall; gross margin holds
H1 2026 revenue fell 22% and net profit fell 31%, while gross margin stayed strong at 68%.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results.
H1 2026 revenue fell 22% and net profit fell 31%, while gross margin stayed strong at 68%.